Literature DB >> 20134300

ACOG Committee Opinion No. 449: Maternal phenylketonuria.

.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive disorder of phenylalanine (Phe) metabolism characterized by a deficiency of the hepatic enzyme, phenylalanine hydroxylase, an enzyme responsible for the conversion of phenylalanine to tyrosine, and elevated levels of Phe and Phe metabolite. All women with PKU or hyperphenylalaninemia should be strongly encouraged to receive family planning and preconception counseling. Women with PKU or hyperphenylalaninemia should begin appropriate, medically directed dietary phenylalanine restriction before conception.

Entities:  

Mesh:

Year:  2009        PMID: 20134300     DOI: 10.1097/AOG.0b013e3181c6f93d

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Newborn screening and the obstetrician.

Authors:  Nancy C Rose; Siobhan M Dolan
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

2.  Views of preimplantation genetic diagnosis among psychiatrists and neurologists.

Authors:  Robert Klitzman; Kristopher J Abbate; Wendy K Chung; Ruth Ottman; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  J Reprod Med       Date:  2014 Jul-Aug       Impact factor: 0.142

3.  Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy.

Authors:  Carmen Rohde; Alena Gerlinde Thiele; Christoph Baerwald; Rudolf Georg Ascherl; Dinah Lier; Ulrike Och; Christina Heller; Alexandra Jung; Kathrin Schönherr; Monika Joerg-Streller; Simone Luttat; Sabine Matzgen; Tina Winkler; Stefanie Rosenbaum-Fabian; Oxana Joos; Skadi Beblo
Journal:  Orphanet J Rare Dis       Date:  2021-11-18       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.